Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study (eLife, 2023)

(untitled) - Flower, B; Hung, LM; Mccabe, L; Ansari, MA; Hoglund, RM; Tarning, J; Kestelyn, E; van Doorn, R; Van Nuil, JI; Thwaites, GE; Barnes, E; Rahman, M; et al.